BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback